Product Program year 2025 Source: CMS Open Payments

Ruby-Fill

Drug Diagnostic

NDC 65174-021-10

Open in the dashboard

General payments

$96,796

37 payments

Research payments

$0

0 payments

Through program year 2025, $96,796 in general payments and $0 in research payments were reported against Ruby-Fill (Diagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $8,230 6
2024 General $148 1
2023 General $60,575 3
2022 General $12,468 20
2021 General $13,051 5
2020 General $2,324 2

Breakdown

Who paid General payments · program years 2020–2025
  1. Jubilant DraxImage Inc. $88,566 31 payments
  2. Jubilant DraxImage, Inc. $8,230 6 payments
Top recipients General payments · program year 2025
  1. Howard Lewin Nuclear Cardiology · Los Angeles, CA $5,100 62% · 1 payment
  2. Mouaz Al-Mallah Cardiovascular Disease · Detroit, MI $2,750 33% · 1 payment
  3. Navid Homayouni Nuclear Radiology · Washington, DC $190 2% · 2 payments
  4. Carlos Garcia Nuclear Medicine · Washington, DC $190 2% · 2 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Nuclear Cardiology Nuclear Medicine $5,100 62% · 1 practitioner
  2. Cardiovascular Disease Internal Medicine $2,750 33% · 1 practitioner
  3. Nuclear Medicine $190 2% · 1 practitioner
  4. Nuclear Radiology Radiology $190 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $5,100 62% · 1 recipient
  2. Texas $2,750 33% · 1 recipient
  3. District of Columbia $380 5% · 2 recipients

Each share is of general payments naming this product in 2025 where a state was reported.

37 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record